DOE PAGES title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Structural characterization of a protective epitope spanning A(H1N1)pdm09 influenza virus neuraminidase monomers

Abstract

A(H1N1)pdm09 influenza A viruses predominated in the 2013–2014 USA influenza season, and although most of these viruses remain sensitive to Food and Drug Administration-approved neuraminidase (NA) inhibitors, alternative therapies are needed. Here we show that monoclonal antibody CD6, selected for binding to the NA of the prototypic A(H1N1)pdm09 virus, A/California/07/2009, protects mice against lethal virus challenge. The crystal structure of NA in complex with CD6 Fab reveals a unique epitope, where the heavy-chain complementarity determining regions (HCDRs) 1 and 2 bind one NA monomer, the light-chain CDR2 binds the neighbouring monomer, whereas HCDR3 interacts with both monomers. This 30-amino-acid epitope spans the lateral face of an NA dimer and is conserved among circulating A(H1N1)pdm09 viruses. These results suggest that the large, lateral CD6 epitope may be an effective target of antibodies selected for development as therapeutic agents against circulating H1N1 influenza viruses.

Authors:
 [1];  [2];  [2];  [2];  [1];  [1];  [1];  [2];  [2];  [2];  [1]
  1. Food and Drug Administration, Silver Springs, MD (United States)
  2. Centers for Disease Control and Prevention, Atlanta, GA (United States)
Publication Date:
Research Org.:
Argonne National Laboratory (ANL), Argonne, IL (United States)
Sponsoring Org.:
USDOE Office of Science (SC), Basic Energy Sciences (BES); Food and Drug Administration and the Centers for Disease Control and Prevention
OSTI Identifier:
1245874
Grant/Contract Number:  
AC02-06CH11357
Resource Type:
Accepted Manuscript
Journal Name:
Nature Communications
Additional Journal Information:
Journal Volume: 6; Journal Issue: 1; Journal ID: ISSN 2041-1723
Publisher:
Nature Publishing Group
Country of Publication:
United States
Language:
ENGLISH
Subject:
59 BASIC BIOLOGICAL SCIENCES; Drug development; Influenza virus; Molecularly targeted therapy

Citation Formats

Wan, Hongquan, Yang, Hua, Shore, David A., Garten, Rebecca J., Couzens, Laura, Gao, Jin, Jiang, Lianlian, Carney, Paul J., Villanueva, Julie, Stevens, James, and Eichelberger, Maryna C. Structural characterization of a protective epitope spanning A(H1N1)pdm09 influenza virus neuraminidase monomers. United States: N. p., 2015. Web. doi:10.1038/ncomms7114.
Wan, Hongquan, Yang, Hua, Shore, David A., Garten, Rebecca J., Couzens, Laura, Gao, Jin, Jiang, Lianlian, Carney, Paul J., Villanueva, Julie, Stevens, James, & Eichelberger, Maryna C. Structural characterization of a protective epitope spanning A(H1N1)pdm09 influenza virus neuraminidase monomers. United States. https://doi.org/10.1038/ncomms7114
Wan, Hongquan, Yang, Hua, Shore, David A., Garten, Rebecca J., Couzens, Laura, Gao, Jin, Jiang, Lianlian, Carney, Paul J., Villanueva, Julie, Stevens, James, and Eichelberger, Maryna C. Tue . "Structural characterization of a protective epitope spanning A(H1N1)pdm09 influenza virus neuraminidase monomers". United States. https://doi.org/10.1038/ncomms7114. https://www.osti.gov/servlets/purl/1245874.
@article{osti_1245874,
title = {Structural characterization of a protective epitope spanning A(H1N1)pdm09 influenza virus neuraminidase monomers},
author = {Wan, Hongquan and Yang, Hua and Shore, David A. and Garten, Rebecca J. and Couzens, Laura and Gao, Jin and Jiang, Lianlian and Carney, Paul J. and Villanueva, Julie and Stevens, James and Eichelberger, Maryna C.},
abstractNote = {A(H1N1)pdm09 influenza A viruses predominated in the 2013–2014 USA influenza season, and although most of these viruses remain sensitive to Food and Drug Administration-approved neuraminidase (NA) inhibitors, alternative therapies are needed. Here we show that monoclonal antibody CD6, selected for binding to the NA of the prototypic A(H1N1)pdm09 virus, A/California/07/2009, protects mice against lethal virus challenge. The crystal structure of NA in complex with CD6 Fab reveals a unique epitope, where the heavy-chain complementarity determining regions (HCDRs) 1 and 2 bind one NA monomer, the light-chain CDR2 binds the neighbouring monomer, whereas HCDR3 interacts with both monomers. This 30-amino-acid epitope spans the lateral face of an NA dimer and is conserved among circulating A(H1N1)pdm09 viruses. These results suggest that the large, lateral CD6 epitope may be an effective target of antibodies selected for development as therapeutic agents against circulating H1N1 influenza viruses.},
doi = {10.1038/ncomms7114},
journal = {Nature Communications},
number = 1,
volume = 6,
place = {United States},
year = {Tue Feb 10 00:00:00 EST 2015},
month = {Tue Feb 10 00:00:00 EST 2015}
}

Journal Article:
Free Publicly Available Full Text
Publisher's Version of Record

Citation Metrics:
Cited by: 66 works
Citation information provided by
Web of Science

Save / Share:

Works referenced in this record:

An optimized enzyme-linked lectin assay to measure influenza A virus neuraminidase inhibition antibody titers in human sera
journal, December 2014


The 2009 pandemic H1N1 neuraminidase N1 lacks the 150-cavity in its active site
journal, September 2010

  • Li, Qing; Qi, Jianxun; Zhang, Wei
  • Nature Structural & Molecular Biology, Vol. 17, Issue 10
  • DOI: 10.1038/nsmb.1909

Universal anti-neuraminidase antibody inhibiting all influenza A subtypes
journal, November 2013


Prevention of influenza by targeting host receptors using engineered proteins
journal, April 2014

  • Connaris, H.; Govorkova, E. A.; Ligertwood, Y.
  • Proceedings of the National Academy of Sciences, Vol. 111, Issue 17
  • DOI: 10.1073/pnas.1404205111

Direct Observation of an Enamine Intermediate in Amine Catalysis
journal, December 2009

  • Zhu, Xueyong; Tanaka, Fujie; Lerner, Richard A.
  • Journal of the American Chemical Society, Vol. 131, Issue 51
  • DOI: 10.1021/ja907271a

Rapid Selection of Oseltamivir‐ and Peramivir‐Resistant Pandemic H1N1 Virus during Therapy in 2 Immunocompromised Hosts
journal, May 2010

  • Memoli, Matthew J.; Hrabal, Rachel J.; Hassantoufighi, Arash
  • Clinical Infectious Diseases, Vol. 50, Issue 9
  • DOI: 10.1086/651605

Structural Characterization of the 1918 Influenza Virus H1N1 Neuraminidase
journal, August 2008


MolProbity: all-atom contacts and structure validation for proteins and nucleic acids
journal, May 2007

  • Davis, I. W.; Leaver-Fay, A.; Chen, V. B.
  • Nucleic Acids Research, Vol. 35, Issue Web Server
  • DOI: 10.1093/nar/gkm216

Mechanism of 150-cavity formation in influenza neuraminidase
journal, July 2011

  • Amaro, Rommie E.; Swift, Robert V.; Votapka, Lane
  • Nature Communications, Vol. 2, Issue 1
  • DOI: 10.1038/ncomms1390

Antibody Recognition of a Highly Conserved Influenza Virus Epitope
journal, April 2009


Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses
journal, February 2009

  • Sui, Jianhua; Hwang, William C.; Perez, Sandra
  • Nature Structural & Molecular Biology, Vol. 16, Issue 3
  • DOI: 10.1038/nsmb.1566

The CCP4 suite programs for protein crystallography
journal, September 1994


Antigenic structure and variation in an influenza virus N9 neuraminidase.
journal, January 1987


Structural basis for the binding of an anti-cytochrome c antibody to its antigen: crystal structures of FabE8-cytochrome c complex to 1.8 å resolution and FabE8 to 2.26 å resolution
journal, August 1998

  • Mylvaganam, Shankari E.; Paterson, Yvonne; Getzoff, Elizabeth D.
  • Journal of Molecular Biology, Vol. 281, Issue 2
  • DOI: 10.1006/jmbi.1998.1942

Inference of Macromolecular Assemblies from Crystalline State
journal, September 2007


Contacts between Influenza Virus N9 Neuraminidase and Monoclonal Antibody NC10
journal, September 2002


Location of antigenic sites on the three-dimensional structure of the influenza N2 virus neuraminidase
journal, September 1985


Conserved Neutralizing Epitope at Globular Head of Hemagglutinin in H3N2 Influenza Viruses
journal, April 2014


Parenteral Peramivir Treatment for Oseltamivir-Resistant 2009 Pandemic Influenza A H1N1 Viruses
journal, September 2011

  • Abed, Y.; Boivin, G.; Yoshida, R.
  • Journal of Infectious Diseases, Vol. 204, Issue 10
  • DOI: 10.1093/infdis/jir610

IMGT/V-QUEST: the highly customized and integrated system for IG and TR standardized V-J and V-D-J sequence analysis
journal, May 2008

  • Brochet, X.; Lefranc, M. -P.; Giudicelli, V.
  • Nucleic Acids Research, Vol. 36, Issue Web Server
  • DOI: 10.1093/nar/gkn316

Refined crystal structure of the influenza virus N9 neuraminidase-NC41 Fab complex
journal, September 1992


Coot model-building tools for molecular graphics
journal, November 2004

  • Emsley, Paul; Cowtan, Kevin
  • Acta Crystallographica Section D Biological Crystallography, Vol. 60, Issue 12, p. 2126-2132
  • DOI: 10.1107/S0907444904019158

Structural basis for the binding of an anti-cytochrome c antibody to its antigen: crystal structures of FabE8-cytochrome c complex to 1.8 å resolution and FabE8 to 2.26 å resolution
journal, August 1998

  • Mylvaganam, Shankari E.; Paterson, Yvonne; Getzoff, Elizabeth D.
  • Journal of Molecular Biology, Vol. 281, Issue 2
  • DOI: 10.1006/jmbi.1998.1942

Antibody Epitopes on the Neuraminidase of a Recent H3N2 Influenza Virus (A/Memphis/31/98)
journal, December 2002


An Antibody That Prevents the Hemagglutinin Low pH Fusogenic Transition
journal, March 2002


Contacts between Influenza Virus N9 Neuraminidase and Monoclonal Antibody NC10
journal, September 2002


MEGA5: Molecular Evolutionary Genetics Analysis Using Maximum Likelihood, Evolutionary Distance, and Maximum Parsimony Methods
journal, May 2011

  • Tamura, K.; Peterson, D.; Peterson, N.
  • Molecular Biology and Evolution, Vol. 28, Issue 10
  • DOI: 10.1093/molbev/msr121

New World Bats Harbor Diverse Influenza A Viruses
journal, October 2013


Three-dimensional structure of a complex of antibody with influenza virus neuraminidase
journal, March 1987

  • Colman, P. M.; Laver, W. G.; Varghese, J. N.
  • Nature, Vol. 326, Issue 6111
  • DOI: 10.1038/326358a0

A monoclonal antibody targeting a highly conserved epitope in influenza B neuraminidase provides protection against drug resistant strains
journal, November 2013

  • Doyle, Tracey M.; Li, Changgui; Bucher, Doris J.
  • Biochemical and Biophysical Research Communications, Vol. 441, Issue 1
  • DOI: 10.1016/j.bbrc.2013.10.041

An Epidemiologically Significant Epitope of a 1998 Human Influenza Virus Neuraminidase Forms a Highly Hydrated Interface in the NA–Antibody Complex
journal, February 2006

  • Venkatramani, Lalitha; Bochkareva, Elena; Lee, Janis T.
  • Journal of Molecular Biology, Vol. 356, Issue 3
  • DOI: 10.1016/j.jmb.2005.11.061

[20] Processing of X-ray diffraction data collected in oscillation mode
book, January 1997


Antibody Recognition of a Highly Conserved Influenza Virus Epitope
journal, April 2009


MolProbity: all-atom contacts and structure validation for proteins and nucleic acids
text, January 2007

  • B., Chen, Vincent; C., Richardson, David; S., Richardson, Jane
  • The University of North Carolina at Chapel Hill University Libraries
  • DOI: 10.17615/m2an-p252

An optimized enzyme-linked lectin assay to measure influenza A virus neuraminidase inhibition antibody titers in human sera
journal, December 2014


Bayesian Phylogenetics with BEAUti and the BEAST 1.7
journal, February 2012

  • Drummond, Alexei J.; Suchard, Marc A.; Xie, Dong
  • Molecular Biology and Evolution, Vol. 29, Issue 8
  • DOI: 10.1093/molbev/mss075

Inference of Macromolecular Assemblies from Crystalline State
journal, September 2007


New World Bats Harbor Diverse Influenza A Viruses
journal, October 2013


Prevention of influenza by targeting host receptors using engineered proteins
journal, April 2014

  • Connaris, H.; Govorkova, E. A.; Ligertwood, Y.
  • Proceedings of the National Academy of Sciences, Vol. 111, Issue 17
  • DOI: 10.1073/pnas.1404205111

An influenza N1 neuraminidase-specific monoclonal antibody with broad neuraminidase inhibition activity against H5N1 HPAI viruses
journal, January 2011

  • Shoji, Yoko; Chichester, Jessica A.; Palmer, Gene A.
  • Human Vaccines, Vol. 7, Issue sup1
  • DOI: 10.4161/hv.7.0.14595

Universal primer set for the full-length amplification of all influenza A viruses
journal, December 2001


Hyperimmune IV Immunoglobulin Treatment
journal, August 2013

  • Hung, Ivan F. N.; To, Kelvin K. W.; Lee, Cheuk-Kwong
  • Chest, Vol. 144, Issue 2
  • DOI: 10.1378/chest.12-2907

An Epidemiologically Significant Epitope of a 1998 Human Influenza Virus Neuraminidase Forms a Highly Hydrated Interface in the NA–Antibody Complex
journal, February 2006

  • Venkatramani, Lalitha; Bochkareva, Elena; Lee, Janis T.
  • Journal of Molecular Biology, Vol. 356, Issue 3
  • DOI: 10.1016/j.jmb.2005.11.061

Likelihood-enhanced fast translation functions
journal, March 2005

  • McCoy, Airlie J.; Grosse-Kunstleve, Ralf W.; Storoni, Laurent C.
  • Acta Crystallographica Section D Biological Crystallography, Vol. 61, Issue 4
  • DOI: 10.1107/S0907444905001617

Oseltamivir-Resistant Pandemic (H1N1) 2009 Virus Infections, United States, 2010–11
journal, February 2012

  • Storms, Aaron D.; Gubareva, Larisa V.; Su, Su
  • Emerging Infectious Diseases, Vol. 18, Issue 2
  • DOI: 10.3201/eid1802.111466

H1N1 2009 Pandemic Influenza Virus: Resistance of the I223R Neuraminidase Mutant Explained by Kinetic and Structural Analysis
journal, September 2012


H1N1 2009 Pandemic Influenza Virus: Resistance of the I223R Neuraminidase Mutant Explained by Kinetic and Structural Analysis
journal, September 2012


Neuraminidase Inhibitors for Influenza
journal, September 2005


Location of antigenic sites on the three-dimensional structure of the influenza N2 virus neuraminidase
journal, September 1985


MultiDrug-Resistant 2009 Pandemic Influenza A(H1N1) Viruses Maintain Fitness and Transmissibility in Ferrets
journal, February 2011

  • Memoli, Matthew J.; Davis, A. Sally; Proudfoot, Kathleen
  • The Journal of Infectious Diseases, Vol. 203, Issue 3
  • DOI: 10.1093/infdis/jiq067

Pooled Human Immunoglobulin Therapy in Critically Ill Patients With Pandemic 2009 Influenza A(H1N1) Pneumonitis and Immunoglobulin G2 Subclass (IgG2) Deficiency
journal, December 2010

  • Gordon, C. L.; Langan, K.; Charles, P. G. P.
  • Clinical Infectious Diseases, Vol. 52, Issue 3
  • DOI: 10.1093/cid/ciq082

Use of TLS parameters to model anisotropic displacements in macromolecular refinement
journal, January 2001

  • Winn, M. D.; Isupov, M. N.; Murshudov, G. N.
  • Acta Crystallographica Section D Biological Crystallography, Vol. 57, Issue 1
  • DOI: 10.1107/S0907444900014736

Developing New Antiviral Agents for Influenza Treatment: What Does the Future Hold?
journal, January 2009

  • Hayden, Frederick
  • Clinical Infectious Diseases, Vol. 48, Issue S1
  • DOI: 10.1086/591851

Mechanism of 150-cavity formation in influenza neuraminidase
journal, July 2011

  • Amaro, Rommie E.; Swift, Robert V.; Votapka, Lane
  • Nature Communications, Vol. 2, Issue 1
  • DOI: 10.1038/ncomms1390

A Neutralizing Antibody Selected from Plasma Cells That Binds to Group 1 and Group 2 Influenza A Hemagglutinins
journal, July 2011


A monoclonal antibody targeting a highly conserved epitope in influenza B neuraminidase provides protection against drug resistant strains
journal, November 2013

  • Doyle, Tracey M.; Li, Changgui; Bucher, Doris J.
  • Biochemical and Biophysical Research Communications, Vol. 441, Issue 1
  • DOI: 10.1016/j.bbrc.2013.10.041

Universal anti-neuraminidase antibody inhibiting all influenza A subtypes
journal, November 2013


MEGA5: Molecular Evolutionary Genetics Analysis Using Maximum Likelihood, Evolutionary Distance, and Maximum Parsimony Methods
journal, May 2011

  • Tamura, K.; Peterson, D.; Peterson, N.
  • Molecular Biology and Evolution, Vol. 28, Issue 10
  • DOI: 10.1093/molbev/msr121

An influenza N1 neuraminidase-specific monoclonal antibody with broad neuraminidase inhibition activity against H5N1 HPAI viruses
journal, January 2011

  • Shoji, Yoko; Chichester, Jessica A.; Palmer, Gene A.
  • Human Vaccines, Vol. 7, Issue sup1
  • DOI: 10.4161/hv.7.0.14595

Antigenicity of the N8 influenza A virus neuraminidase: existence of an epitope at the subunit interface of the neuraminidase.
journal, January 1994


The 2009 pandemic H1N1 neuraminidase N1 lacks the 150-cavity in its active site
journal, September 2010

  • Li, Qing; Qi, Jianxun; Zhang, Wei
  • Nature Structural & Molecular Biology, Vol. 17, Issue 10
  • DOI: 10.1038/nsmb.1909

Antigenicity of the N8 influenza A virus neuraminidase: existence of an epitope at the subunit interface of the neuraminidase.
journal, January 1994


Antigenic structure and variation in an influenza virus N9 neuraminidase.
journal, January 1987


Works referencing / citing this record:

Antigenic drift originating from changes to the lateral surface of the neuraminidase head of influenza A virus
journal, March 2019


Neuraminidase-Inhibiting Antibody Titers Correlate with Protection from Heterologous Influenza Virus Strains of the Same Neuraminidase Subtype
journal, June 2018

  • Walz, Lisa; Kays, Sarah-Katharina; Zimmer, Gert
  • Journal of Virology, Vol. 92, Issue 17
  • DOI: 10.1128/jvi.01006-18

Influenza virus neuraminidase (NA): a target for antivirals and vaccines
journal, June 2016

  • Jagadesh, Anitha; Salam, Abdul Ajees Abdul; Mudgal, Piya Paul
  • Archives of Virology, Vol. 161, Issue 8
  • DOI: 10.1007/s00705-016-2907-7

Fcγ Receptors Contribute to the Antiviral Properties of Influenza Virus Neuraminidase-Specific Antibodies
journal, October 2019


Broadly protective human antibodies that target the active site of influenza virus neuraminidase
journal, October 2019


Neuraminidase-Inhibiting Antibody Titers Correlate with Protection from Heterologous Influenza Virus Strains of the Same Neuraminidase Subtype.
text, January 2018

  • Walz, Lisa; Kays, Sarah-Katharina; Zimmer, Gert
  • American Society for Microbiology
  • DOI: 10.7892/boris.127508

Double‐Layered M2e‐NA Protein Nanoparticle Immunization Induces Broad Cross‐Protection against Different Influenza Viruses in Mice
journal, December 2019

  • Wang, Ye; Deng, Lei; Gonzalez, Gilbert X.
  • Advanced Healthcare Materials, Vol. 9, Issue 2
  • DOI: 10.1002/adhm.201901176

Whole Genome Sequencing of A(H3N2) Influenza Viruses Reveals Variants Associated with Severity during the 2016–2017 Season
journal, January 2019

  • Simon, Bruno; Pichon, Maxime; Valette, Martine
  • Viruses, Vol. 11, Issue 2
  • DOI: 10.3390/v11020108

Broadly inhibiting antineuraminidase monoclonal antibodies induced by trivalent influenza vaccine and H7N9 infection in humans.
text, January 2020


Neuraminidase, the Forgotten Surface Antigen, Emerges as an Influenza Vaccine Target for Broadened Protection
journal, April 2019

  • Eichelberger, Maryna C.; Monto, Arnold S.
  • The Journal of Infectious Diseases, Vol. 219, Issue Supplement_1
  • DOI: 10.1093/infdis/jiz017

Genetic analysis of neuraminidase gene of influenza A(H1N1)pdm09 virus circulating in Southwest India from 2009 to 2012: Genetic Analysis of NA Gene of Influenza A(H1N1)pdm09 Virus
journal, July 2016

  • Jagadesh, Anitha; Salam, Abdul Ajees Abdul; Zadeh, Vahid Rajabali
  • Journal of Medical Virology, Vol. 89, Issue 2
  • DOI: 10.1002/jmv.24625

Recombinant heat shock protein 78 enhances enterovirus 71 propagation in Vero cells and is induced in SK-N-SH cells during the infection
journal, February 2017


New options to treat influenza B
journal, September 2017


Effector mechanisms of influenza-specific antibodies: neutralization and beyond
journal, September 2018